Prescribing Problems and Pharmacist Interventions in Community Practice

Rupp, Michael T.; DeYoung, Michael; Schondelmeyer, Stephen W.

doi:10.1097/00005650-199210000-00005

Cited by 166 publications

(110 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…2 Community pharmacists can contribute to the prevention and identification of DRPs, with pharmacists' interventions being associated with reduced hospital admissions, 3 and prevention of possible patient harm. [4][5][6] In a study of Currie and colleagues, the effect of a training program on the detection of DRPs was investigated. The training program led to an increase in the detection of DRPs.…”

Section: Management Of Drug Interactions With Beta-blockers: Continuimentioning

confidence: 99%

Manejo de las interacciones medicamentosas con beta-bloqueantes: la formación continuada tiene impacto a corto plazo

Driesen¹,

Simoens²,

Laekeman³

2006

Pharmacy pract. (Granada Ed. impr.)

View full text Add to dashboard Cite

*There is a lack of clear guidelines regarding the management of drug-drug interactions. Objective: To assess the impact of an educational intervention on the management of drug interactions with beta-blockers. Methods: The study had a controlled before-andafter design. The intervention group (n=10 pharmacies) received a continuing education course and guidelines on the management of drug interactions with beta-blockers. The control group (n=10 pharmacies) received no intervention. Pharmacy students and staff of internship pharmacies participated in this study. Before and after the intervention, students registered interactions with beta-blockers during two weeks. Information was obtained on drug information of the beta-blocker and the interacting drug, patient's demographics, and the mode of transaction. Results: A total number of 288 interactions were detected during both study periods. Most betablockers causing an interaction were prescribed for hypertension, and interacted with hypoglycemic agents, NSAIDs, or beta2-agonists. Pharmacists' intervention rate was low (14% in the pre-test compared to 39% in the post-test), but increased significantly in the post-test in the intervention group. Reasons for overriding the interaction included limited clinical relevance, refill prescriptions, not being aware of the interaction, and communication problems with the prescriber. Conclusion: An interactive continuing education course, during which practice-oriented guidelines were offered, affected pharmacists' short-term behavior at the counter in dealing with interactions of beta-blockers. Continuing education plays a role in raising pharmacists' awareness and responsibility towards the detection and management of drug interactions in the pharmacy.

show abstract

Section: Management Of Drug Interactions With Beta-blockers: Continuimentioning

confidence: 99%

Manejo de las interacciones medicamentosas con beta-bloqueantes: la formación continuada tiene impacto a corto plazo

Driesen¹,

Simoens²,

Laekeman³

2006

Pharmacy pract. (Granada Ed. impr.)

View full text Add to dashboard Cite

show abstract

“…These studies have documented a problem detection and intervention rate of between 1% and 5% of all prescriptions dispensed, with changes in drug therapy occurring 40% or more of the time. 23,24 In one long-term OBRA '90 demonstration study, Christensen et al 25 documented pharmacist cognitive services over a 20-month period. The most common type of drug problem intervention involved patient-specific understanding of instructions for use and medication compliance rather than problems with the drug or drug regimen itself.…”

Section: Pharmacists' Performancementioning

confidence: 99%

Current Status of Prospective Drug Utilization Review

Fulda¹,

Lyles²,

Pugh³

et al. 2004

JMCP

View full text Add to dashboard Cite

“…A integração entre prescritores e dispensadores permite, através da combinação de conhecimentos especializados e complementares, o alcance de resultados eficientes, beneficiando o paciente (Rupp et al, 1992).…”

Section: Troca De Informações E Interação Entre Paciente/prescritor/dunclassified

“…Este profissional encontra-se na interface entre a distribuição de fármacos e o seu uso, podendo ser considerado como peça-chave na garantia da qualidade do cuidado médico (Rupp et al, 1992). Ele representa uma das últimas oportunidades de, ainda dentro do sistema de saúde, identificar, corrigir ou reduzir possíveis riscos associados à terapêutica.…”

Section: Troca De Informações E Interação Entre Paciente/prescritor/dunclassified

A interação entre prescritores, dispensadores e pacientes: informação compartilhada como possível benefício terapêutico

Pepe

Castro

2000

Cad. Saúde Pública

View full text Add to dashboard Cite

The article presents a critical view of the interaction between prescribers, dispensers, and patients, considering information one of the key issues in enhancing the qualitative aspects involved in this complex relationship. It describes the acquisition of information by health professionals, possible sources of this information, and the process involved in transforming it into knowledge. Briefly discussed are the physician's and pharmacist's roles, the patient's expectations as recipient, and consequences of pertinent health interventions. Key words

show abstract

Prescribing Problems and Pharmacist Interventions in Community Practice

Cited by 166 publications

References 15 publications

Manejo de las interacciones medicamentosas con beta-bloqueantes: la formación continuada tiene impacto a corto plazo

Manejo de las interacciones medicamentosas con beta-bloqueantes: la formación continuada tiene impacto a corto plazo

Current Status of Prospective Drug Utilization Review

A interação entre prescritores, dispensadores e pacientes: informação compartilhada como possível benefício terapêutico

Contact Info

Product

Resources

About